serine has been researched along with Dyskinesia, Medication-Induced in 7 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While Parkinson's disease (PD) phenotype in leucine-rich repeat kinase 2 gene (LRRK2)-associated and sporadic PD seems similar, there is paucity of data on the possible effect of mutations in LRRK2 on response to and complications of dopaminergic therapy." | 1.38 | Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. ( Cohen, OS; Friedman, E; Hassin-Baer, S; Inzelberg, R; Kaplan, N; Korczyn, AD; Kozlova, E; Rosset, S; Vituri, A; Yahalom, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paus, S | 1 |
| Gadow, F | 1 |
| Knapp, M | 1 |
| Klein, C | 1 |
| Klockgether, T | 1 |
| Wüllner, U | 1 |
| Morissette, M | 1 |
| Samadi, P | 1 |
| Hadj Tahar, A | 1 |
| Bélanger, N | 1 |
| Di Paolo, T | 1 |
| Yahalom, G | 1 |
| Kaplan, N | 1 |
| Vituri, A | 1 |
| Cohen, OS | 1 |
| Inzelberg, R | 1 |
| Kozlova, E | 1 |
| Korczyn, AD | 1 |
| Rosset, S | 1 |
| Friedman, E | 1 |
| Hassin-Baer, S | 1 |
| Bakker, PR | 1 |
| van Harten, PN | 1 |
| van Os, J | 1 |
| Liou, YJ | 1 |
| Lai, IC | 1 |
| Liao, DL | 1 |
| Chen, JY | 1 |
| Lin, CC | 1 |
| Lin, CY | 1 |
| Chen, CM | 1 |
| Bai, YM | 1 |
| Chen, TT | 1 |
| Wang, YC | 1 |
| Segman, R | 1 |
| Neeman, T | 1 |
| Heresco-Levy, U | 1 |
| Finkel, B | 1 |
| Karagichev, L | 1 |
| Schlafman, M | 1 |
| Dorevitch, A | 1 |
| Yakir, A | 1 |
| Lerner, A | 1 |
| Shelevoy, A | 1 |
| Lerer, B | 2 |
| Segman, RH | 1 |
| Fangerau, H | 1 |
| Daly, AK | 1 |
| Basile, VS | 1 |
| Cavallaro, R | 1 |
| Aschauer, HN | 1 |
| McCreadie, RG | 1 |
| Ohlraun, S | 1 |
| Ferrier, N | 1 |
| Masellis, M | 1 |
| Verga, M | 1 |
| Scharfetter, J | 1 |
| Rietschel, M | 1 |
| Lovlie, R | 1 |
| Levy, UH | 1 |
| Meltzer, HY | 1 |
| Kennedy, JL | 1 |
| Steen, VM | 1 |
| Macciardi, F | 1 |
1 review available for serine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Topics: Adult; Aged; Analysis of Variance; Chi-Square Distribution; Confidence Intervals; Dyskinesia, Drug-I | 2002 |
6 other studies available for serine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Community Networks; Dyskinesia, Drug-Induced; Female; | 2009 |
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
Topics: Animals; Antiparkinson Agents; Benzoxazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; D | 2010 |
Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
Topics: Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Dyskinesia, Drug-Induced; Female; Gene Freq | 2012 |
Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.
Topics: Alleles; Antipsychotic Agents; Chi-Square Distribution; Dyskinesia, Drug-Induced; Female; Glycine; H | 2006 |
The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia.
Topics: Antipsychotic Agents; Case-Control Studies; Dyskinesia, Drug-Induced; Female; Genetic Predisposition | 2006 |
Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Genotype; Glycine; Humans; Israel; Je | 1999 |